` GBLX (GB Sciences Inc) vs NOVO B (Novo Nordisk A/S) Comparison - Alpha Spread

GBLX
vs
NOVO B

Over the past 12 months, GBLX has underperformed NOVO B, delivering a return of -98% compared to the NOVO B's 55% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
GBLX
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

GBLX Intrinsic Value
1.0E-5 USD
Overvaluation 97%
Intrinsic Value
Price
NOVO B Intrinsic Value
633.49 DKK
Undervaluation 31%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
GB Sciences Inc
OTC:GBLX
0.0002 USD
Novo Nordisk A/S
CSE:NOVO B
438.95 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
GBLX vs NOVO B

GBLX
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
GB Sciences Inc
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
GBLX vs NOVO B

GBLX
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
GB Sciences Inc
OTC:GBLX
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

GBLX
0%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

Operating Margin

GBLX
0%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

Net Margin

GBLX
0%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

FCF Margin

GBLX
0%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

ROE

GBLX
33.7%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

ROA

GBLX
-723.4%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

ROIC

GBLX
75%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

ROCE

GBLX
30.2%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
GB Sciences Inc
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
GBLX vs NOVO B

Loading
GBLX
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
GBLX vs NOVO B

Loading
GBLX
NOVO B
Difference
www.alphaspread.com

Performance By Year
GBLX vs NOVO B

Loading
GBLX
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare GBLX to other stocks
Unlock Full Access to Alpha Spread
Create Free Account